全文获取类型
收费全文 | 17001篇 |
免费 | 1697篇 |
国内免费 | 1116篇 |
专业分类
耳鼻咽喉 | 120篇 |
儿科学 | 146篇 |
妇产科学 | 239篇 |
基础医学 | 3770篇 |
口腔科学 | 333篇 |
临床医学 | 1661篇 |
内科学 | 3446篇 |
皮肤病学 | 368篇 |
神经病学 | 896篇 |
特种医学 | 304篇 |
外国民族医学 | 12篇 |
外科学 | 1240篇 |
综合类 | 2554篇 |
现状与发展 | 6篇 |
预防医学 | 653篇 |
眼科学 | 252篇 |
药学 | 1471篇 |
3篇 | |
中国医学 | 156篇 |
肿瘤学 | 2184篇 |
出版年
2024年 | 60篇 |
2023年 | 406篇 |
2022年 | 787篇 |
2021年 | 1156篇 |
2020年 | 754篇 |
2019年 | 700篇 |
2018年 | 572篇 |
2017年 | 522篇 |
2016年 | 606篇 |
2015年 | 733篇 |
2014年 | 997篇 |
2013年 | 998篇 |
2012年 | 1061篇 |
2011年 | 1185篇 |
2010年 | 1046篇 |
2009年 | 1103篇 |
2008年 | 1039篇 |
2007年 | 982篇 |
2006年 | 852篇 |
2005年 | 684篇 |
2004年 | 482篇 |
2003年 | 353篇 |
2002年 | 253篇 |
2001年 | 286篇 |
2000年 | 231篇 |
1999年 | 195篇 |
1998年 | 203篇 |
1997年 | 188篇 |
1996年 | 131篇 |
1995年 | 127篇 |
1994年 | 122篇 |
1993年 | 105篇 |
1992年 | 92篇 |
1991年 | 72篇 |
1990年 | 61篇 |
1989年 | 60篇 |
1988年 | 66篇 |
1987年 | 48篇 |
1986年 | 41篇 |
1985年 | 77篇 |
1984年 | 46篇 |
1983年 | 39篇 |
1982年 | 32篇 |
1981年 | 42篇 |
1980年 | 50篇 |
1979年 | 28篇 |
1978年 | 34篇 |
1977年 | 17篇 |
1976年 | 30篇 |
1975年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
71.
利用重组的丙型肝炎病毒非结构区(HCVNS5)抗原建立了酶免疫试验(EIA),对25例输血后丙型肝炎进行了不同区抗体及丙氨酸转氨酶(ALT)的动态研究,同时对156例慢性丙型肝炎患者血清进行HCVRNA和抗-NS5平行检测,两者符合率为64.1%。抗-NS5抗体首次检出时间为30~575天(182.9±168.5),晚于ALT异常和其他区抗体的出现时间。在感染后1,3,6,12和24个月后抗-NS5的阳性率分别为28%,40%,52%,68%和76%。抗-NS5的动态变化类型为四种:一过性阳性、间歇性阳性、持续性阳性和2年内持续阴性 相似文献
72.
T. Takaki 《Medical & biological engineering & computing》1988,26(4):397-403
The paper considers the limiting factors in EEG enhancement in the presence of electrosurgery interference and presents a
design for a useful fibre-optic EEG monitoring instrument which is free from such problems as electrical shock (micro and
macroshock), patient burns and susceptibility to electrosurgery interference associated with conventional EEG monitors. 相似文献
73.
Isolation and RNA-binding analysis of NAD+-isocitrate dehydrogenases from Kluyveromyces lactis and Schizosaccharomyces pombe 总被引:1,自引:0,他引:1
Krebs cycle NAD+-isocitrate dehydrogenase (Idh) binds to the 5-UTRs of all mitochondrial mRNAs in Saccharomyces cerevisiae. We hypothesize that this leader-binding activity plays a role in translational regulation, thereby linking mitochondrial
biogenesis to the need for respiratory function. Analysis of effects of leader binding on mitochondrial translation is complicated
by the involvement of the enzyme in mitochondrial metabolism. We have therefore searched for an Idh altered in RNA binding,
but retaining full enzyme activity. Idh from Kluyveromyces lactis and Schizosaccharomyces pombe was partially purified and examined for the ability to bind Cox2 mRNA. Sch. pombe Idh, like the S. cerevisiae enzyme, has high affinity for both its own, K. lactis and S. cerevisiaeCOX2 leaders. In contrast, Idh purified from K. lactis shows only low affinity for all mRNAs tested. To determine what distinguishes K. lactis Idh from S. cerevisiae Idh, genes encoding the two subunits of Idh in K. lactis were cloned and sequenced. Sequence comparison revealed high levels of similarity throughout the proteins, in particular
in regions involved in enzyme activity, co-factor and regulator binding. Non-conserved residues between the subunits from
the two yeasts are candidates for involvement in the interaction with RNA.
Received: 19 January 2000 / 24 March 2000 相似文献
74.
J. Rappaport M. W. Richardson P. E. Klotman S. K. Arya G. Baier-Bitterlich 《Journal of molecular medicine (Berlin, Germany)》1995,73(12):583-589
HIV-1 and HIV-2 are co-endemic in certain geographic areas. HIV-2 is more weakly pathogenic than HIV-1, and progression to AIDS occurs less frequently and over a longer period of time. Recent epidemiologic studies suggest that individuals infected with HIV-2 have a lower risk of HIV-1 infection. Both immune mechanisms and various modes of viral interference have been proposed to account for these results. Our findings, described in this paper, suggest that HIV-2 inhibits HIV-1 replication. To study the molecular interactions between HIV-1 and HIV-2, proviral clones were transfected alone or in combination into the human T cell line CEM. LTR-CAT indicator constructs were included for the purpose of monitoring viral promoter activity. Viral replication in transfected cells was monitored by p24 antigen capture assay of cell culture supernatants and Western blot analysis of cell extracts. HIV-2 inhibited HIV-1 replication as determined by intracellular and extracellular p24 antigen levels. Similar results were obtained with simultaneous virus infection using HIV-1 and HIV-2, rather than transfections of proviral DNA. Using cotransfection of HIV-1 and HIV-2 LTR indicator gene constructs, the mechanism of inhibition was found to be suppression of the HIV-1 LTR by HIV-2. The inhibitory effect of HIV-2 is not due to Tat-2, but appears to discriminate between the HIV-1 and HIV-2 LTRs based on differences in the Tat activation response element, TAR. These results suggest both a molecular mechanism for HIV-2 interference with HIV-1 replication and a potential molecular approach to therapy. 相似文献
75.
Dobrev D 《Medical & biological engineering & computing》2002,40(5):546-549
A circuit is proposed for a non-differential two-electrode biopotential amplifier, with a current source and a transimpedance
amplifier as a potential equaliser for its inputs, fully emulating a differential amplifier. The principle of operation is
that the current in the input of the transimpedance amplifier is sensed and made to flow with the same value in the other
input. The circuit has a simple structure and uses a small number of components. The current source maintains balanced common-mode
interference currents, thus ensuring high signal input impedance. In addition, these currents can be tolerated up to more
than 10μA per input, at a supply voltage of ±5V. A two-electrode differential amplifier with 2×10 MΩ input resistances to
the reference point allows less than 0.5μA per input. The circuit can be useful in cases of biosignal acquisition by portable
instruments, using low supply voltages, from subjects in areas of high electromagnetic fields. Examples include biosignal
recordings in electric power stations and electrically powered locomotives, where traditionally designed input amplifier stages
can be saturated. 相似文献
76.
目的 探讨血清HCV RNA检测在预防输血后丙型肝炎中的意义。方法 用ELISA法检测2000年1月至2003年12月末抗.HCV阴性的全血标本56400份次,再进行RT-PCR(荧光适时技术)检测HCV RNA,并对输过HCV RNA筛查阴性血液的患者进行追查。结果 HCVRNA阳性率为2.5‰(146/56400)。对输过HCVRNA筛查阴性血液的患者追查结果,无一例发生输血后丙型肝炎。结论 对抗-HCV阴性的血液标本用敏感的试剂进行HCV RNA检测在预防输血后丙型肝炎中不但有效,而且可行。 相似文献
77.
Alanna M. Kongkriangkai Christopher King Lisa J. Martin Emily Wakefield Carlos E. Prada Geraldine Kelly‐Mancuso Elizabeth K. Schorry 《American journal of medical genetics. Part A》2019,179(4):602-607
Tumor growths, migraine headaches, and other health‐related complications reported in patients with neurofibromatosis type 1 (NF1) are often associated with pain. Thus, this study sought to describe and quantify the pain experience in children and young adults with NF1. Surveys were administered to 49 participants (28 children and 21 adults), ages 8 through 40 years. The survey included the Numeric Rating Scale 11 (NRS11) to assess pain intensity and the Patient Reported Outcomes Measurement Information System (PROMIS) to assess pain interference. A supplemental survey was created to measure pain frequency, chronicity, quality, and location. Results suggest pain is not only present in 55% of the cohort, but that it can begin at early ages. Pain was chronic in 35% of participants, with 41% reporting the use of medication to manage pain symptoms. Common sources of pain included migraine headaches and NF‐related tumors. Pain was described as having neuropathic features (i.e., burning, tingling, numbness, or itching), and was localized to the head, back, and extremities. Further, subsets of participants reported moderate‐to‐severe pain intensity, high frequency of pain, and interference of pain in daily activities. Continued investigation of the pain experience in a multisystem disorder, such as NF1, remains essential to providing guidance in the setting of complex pain management. 相似文献
78.
79.
Eiji Tanaka Kendo Kiyosawa Yoshiyuki Nakatsuji Yoshimichi Inoue Tatsuo Miyamura Joe Chiba Seiichi Furuta 《Journal of medical virology》1993,39(4):318-324
The prevalence of hepatitis C antibodies (anti- HCV) among multitransfused patients was studied and compared with predicted values obtained from a post-transfusion hepatitis study and from data on the prevalence of anti-HCV among blood donors. The prevalence of hepatitis B core antibodies (anti-HBc) was also studied to determine the routes of transmission of hepatitis C virus. The patients consisted of 65 dialysis patients (57 on haemodialysis and 8 on continuous ambulatory peritoneal dialysis) and 71 leukemia patients in long-term remission [49 with acute myeloid leukemia (AML) and 22 with acute lymphatic leukemia (ALL)]. The presence of anti-HCV was investigated using a second generation enzyme-linked immunosorbent assay. Reactive samples were confirmed by a second generation recombinant immunoblot assay. Anti-HBc was studied in the 65 dialysis patients and in 40 of the leukemia patients. Three (4.6%) of the 65 dialysis patients and 12 (24.5%) of the 49 AML patients were anti-HCV positive whereas all of the ALL patients were seronegative. The total number of blood units transfused to 134 patients (data on two dialysis patients were not available) was 18,148, out of which 17,575 units had been transfused prior to the initiation of anti- HCV screening of blood donors. On the basis of the anti-HCV prevalence among blood donors and the incidence of post-transfusion hepatitis, the predicted number of seropositive patients was 11 and 18, respectively. Five of the 65 dialysis patients were anti-HBc positive, compared with only one of the 40 leukemia patients. It is concluded that the anti-HCV prevalence among dialysis and leukemia patients is concordant with the risk of receiving contaminated blood products, whereas hepatitis B infection may have other routes of transmission in dialysis patients. © 1993 Wiley-Liss, Inc. 相似文献
80.
The specification of a germ cell as sperm or oocyte and determination of cell number remain unsolved questions in developmental biology. This paper examines Caenorhabditis elegans FOG-1, a CPEB-related RNA-binding protein that controls the sperm fate. We find that abundant FOG-1 protein is observed transiently in germ cells just prior to their expression of an early sperm-differentiation marker. As the germline tissue elongates, abundant FOG-1 appears more and more distally as sperm become specified, but disappears when the germ line switches to oogenesis. This dynamic pattern is controlled by both globally acting and germline-specific sex-determining regulators. Importantly, the extent of FOG-1 expression corresponds roughly to sperm number in wild-type and mutants, altering sperm number. By contrast, three other key regulators of the sperm/oocyte decision do not similarly correspond to sperm number. We suggest that FOG-1 is precisely modulated in both time and space to specify sperm fate and control sperm number. 相似文献